Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDYS Biopharma Co., Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
YS Biopharma Co., Ltd. Earnings Date And Information
YS Biopharma Co., Ltd. last posted its earnings results on Friday, April 19th, 2024. The company reported $-0.12 earnings per share for the quarter, missing analysts' consensus estimates of $-0.08 by $0.04. The company had revenue of 164.98 M for the quarter and had revenue of 687.20 M for the year. YS Biopharma Co., Ltd. has generated $-2 earnings per share over the last year ($-1.56 diluted earnings per share) and currently has a price-to-earnings ratio of -0.44. YS Biopharma Co., Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 20th, 2024 based on prior year's report dates.
YS Biopharma Co., Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 01/22/2024 | Q3 2024 | -$0.72 | -$0.84 | -0.12 | $20.11 M | $164.98 M |
| 09/29/2023 | Q2 2024 | N/A | -$1.13 | N/A | $168.62 M | $96.82 M |
| 06/29/2023 | Q1 2024 | N/A | -$0.75 | N/A | N/A | $176.27 M |
| 12/30/2022 | Q3 2023 | N/A | -$0.86 | N/A | N/A | $181.65 M |
| 09/29/2022 | Q2 2023 | N/A | $0.09 | N/A | N/A | $194.06 M |
| 06/29/2022 | Q1 2023 | N/A | -$0.21 | N/A | N/A | $205.48 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
YS Biopharma Co., Ltd. Earnings: FAQ's
YS Biopharma Co., Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 20th, 2024 based offlast year's report dates.
The conference call for YS Biopharma Co., Ltd.'s latest earnings report can be listened to online.
The conference call transcript for YS Biopharma Co., Ltd.'s latest earnings report can be read online.
YS Biopharma Co., Ltd. (:YS) has a recorded annual revenue of $687.20 M.
YS Biopharma Co., Ltd. (:YS) has a recorded net income of $-145,479,105.YS Biopharma Co., Ltd. has generated $-1.56 earnings per share over the last four quarters.
YS Biopharma Co., Ltd. (:YS) has a price-to-earnings ratio of -0.44 and price/earnings-to-growth ratio is -0.01.